At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable biotech and pharma companies to bring large and small molecule medicines to patients in need. From drug substance to the final drug product, our solutions feature concept to commercial capabilities to simplify your outsourcing experience and to provide a reliable outcome when you expect it. Our extensive track record includes development and manufacture of a wide variety of biological and chemical dosage forms including oral solid, parenteral and inhaled delivery routes. We continuously invest to solve not just current, but also future challenges that support commercialization of pioneering therapies. Together, we can bring your next medicine to life.
We manage projects from pre-clinical development stage through to commercialization across mammalian and microbial produced biologics, small molecules, bioconjugates, and cell and gene therapies. Our extensive service portfolio covers both drug substance and drug product. We have strengthened our drug product and particle engineering capabilities and, with the recent acquisition of the former Novartis Stein facility, sterile injectables are also included in our service offering. Our integrated capacity enables you to collaborate with a single service provider for a wide variety of service needs, decreasing the amount of coordination required and saving you time and money.
Our service portfolio is comprehensive, which enables tailoring of a cost-effective and phase-appropriate package that suits your business needs. The following services serve as examples:
- SimpliFiH Solutions™ - Integrated First-in Human Service Package
- Drug substance development and production
- Oral, parenteral, and inhalation formulation development
- Production of drug substance and drug product intermediates
- High potency drug substance and drug product manufacturing
- Analytical method development and validation
- Regulatory consulting
- Lifecycle management
- Scale-up and tech transfer
We have contract development and manufacturing services around the globe. Our major development and manufacturing sites are located in Switzerland, USA, United Kingdom, Singapore, China, France, Spain, the Netherlands, Germany, Belgium, Mexico, India, Indonesia, and Japan. In addition, we have local sales offices in other countries to enable close communication with you.
We serve pharmaceutical and biopharmaceutical companies globally, striving to help reduce capital risk and increase chances of business success. Our customers range in size from small, even virtual companies, to some of the world’s largest drug manufacturers. The motivations for seeking an outsourcing partner will differ depending on company and business strategy. We work in close collaboration with you to ensure that we meet your specific requirements in each specific project.